Geisinger Hazleton Cancer Center is a clinical research site located in Hazleton, Pennsylvania, United States 18201.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Geisinger Hazleton Cancer Center has participated in 52 clinical trials with 1 currently active.
Therapeutic areas: Breast Cancer, Chemotherapeutic Agent Toxicity, Neurotoxicity.
Sponsors: NSABP Foundation Inc, Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group.
Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Geisinger Hazleton Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Geisinger Hazleton Cancer Center has 52 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Chemotherapeutic Agent Toxicity, Neurotoxicity.
Geisinger Hazleton Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.